Clinical Trials on Peripheral T-cell Lymphoma NOS
Total 15457 results
-
Peking UniversityRecruitingPeripheral T-cell LymphomaChina
-
Samsung Medical CenterRecruitingPeripheral T-cell LymphomaKorea, Republic of
-
Ruijin HospitalActive, not recruitingPeripheral T-cell LymphomaChina
-
The Lymphoma Academic Research OrganisationCompletedEfficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell LymphomaPeripheral T-cell LymphomaSpain, France, Korea, Republic of, Italy, Germany, Singapore, Belgium, Portugal
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
Chipscreen Biosciences, Ltd.CompletedPeripheral T-cell LymphomaChina
-
CerRx, Inc.UnknownPeripheral T-cell LymphomaUnited States
-
Mundipharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Mingzhi ZhangZhengzhou UniversityCompleted
-
Solasia Pharma K.K.Synex Consulting Korea Ltd.CompletedPeripheral T-cell LymphomaKorea, Republic of
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell LymphomaUnited States, Canada
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknownAcute Lymphocytic Leukemia | T-lymphoblastic Lymphoma | NK/T Cell LymphomaChina
-
The Lymphoma Academic Research OrganisationInnate PharmaRecruitingPeripheral T Cell Lymphoma | Relapse/RecurrenceFrance, Spain, Belgium, Germany
-
National Cancer Institute (NCI)WithdrawnHepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Extranodal NK-/T-cell Lymphoma, Nasal Type | Monomorphic Epiteliotrophic Intestinal T-cell LymphomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States
-
Taiwan Mundipharma Pharmaceuticals Ltd.UnknownPeripheral T Cell Lymphoma | Progression, DiseaseTaiwan
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapse/Refratory Peripheral T Cell LymphomaChina
-
The First Affiliated Hospital with Nanjing Medical...Active, not recruitingLymphoma, Large B-Cell, Diffuse | Mantle Cell Lymphoma | Peripheral T Cell Lymphoma | Double-hit LymphomaChina
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Completed
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-Hodgkin Lymphoma | NK/T Cell Lymphoma | Vascular Immunomother T Cell LymphomaChina
-
Affimed GmbHCompletedPeripheral T Cell Lymphoma | Transformed Mycosis FungoidesSpain, United States, Korea, Republic of, Italy, France, Australia, Germany, Poland, Turkey, Russian Federation
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Beijing Tongren HospitalRecruitingT-lymphoblastic Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Sun Yat-sen UniversityUnknownLymphoma, | Non-Hodgkin Lymphoma, | Extranodal NK/T-cell Lymphoma,Nasal-type,China
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Washington University School of MedicineWugen, Inc.RecruitingAcute Myeloid Leukemia | Sezary Syndrome | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult T Cell Leukemia | Adult T Cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | T-Cell Non-Hodgkin... and other conditionsUnited States
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
TakedaActive, not recruiting
-
Peking UniversityPeking University International Hospital; Jiangxi Provincial Cancer Hospital; Shandong Tumor HospitalUnknownExperimental TumorChina
-
TakedaRecruitingT-Cell LymphomaFrance, Germany, Spain, Italy
-
University of Medicine and Dentistry of New JerseyOrtho Biotech, Inc.Terminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
Samsung Medical CenterCompletedNon-Hodgkin T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
TakedaCompletedLymphoma, T-Cell, PeripheralSpain
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedLymphoma, T-Cell, PeripheralItaly
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
Peking UniversityNot yet recruitingPeripheral T-cell LymphomaChina
-
CelgeneCompletedLymphoma, T-Cell, PeripheralJapan
-
Ryan WilcoxUniversity of Michigan Rogel Cancer Center; TakedaActive, not recruitingLymphoma, T-Cell, PeripheralUnited States
-
Eisai Inc.CompletedLymphoma, T-Cell, PeripheralUnited States
-
Peking University Cancer Hospital & InstituteBeijing Municipal Administration of HospitalsUnknownLymphoma, T-Cell, PeripheralChina
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States